Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2008-01-01
2008-01-01
Gupta, Anish (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
10477985
ABSTRACT:
The present invention features truncated MCH analogs active at the melanin concentrating hormone type 2 receptor (MCH-2R) and uses of such analogs. Truncated MCH analogs described herein include those active at MCH-2R and MCH-1R, and those selectively active at MCH-2R. MCH-2R analogs have a variety of different uses including being used as a research tool and being used therapeutically.
REFERENCES:
patent: 5049655 (1991-09-01), Vaughan et al.
patent: 5849708 (1998-12-01), Maratos-Flier
patent: 2003/0105278 (2003-06-01), Bednarek
patent: WO 90/11295 (1990-10-01), None
patent: WO 07/57070 (2001-08-01), None
Audinot, V. et al. “Structure-Activity Relationship Studies of Melanin-concentrating Hormone (Mcl-II-related Peptide Ligands at SLC-1, the Human MCH Receptor”, The Journal of Biological Chemistry, 2001, vol. 276, pp. 13554-13562—applicant's submitted IDS.
Audinot et al, Structure-activity relationship studies of melanin-concentrating hormone (MCH)-related peptide ligands at SLC-1, the human MCH receptor, J Biol Chem. Apr. 27, 2001; 276(17):13554-62.
Hinterman E. et al, J. of Receptor and Signal Transduction Research, 19(1-4), 411-422, (1999).
Audinot V, “Structure-activity relationship studies of melanin-concentrating hormone (MCH)-related peptide ligands at SLC-1, the human MCH receptor,” J Biol Chem. Apr. 27, 2001;276(17):13554-62. Epub Jan. 18, 2001.
Audinot, V. et al. “Structure-Activity Relationship Studies of Melanin-concentrating Hormone (MCH)-related Peptide Ligands at SLC-1, the Human MCH Receptor”, The Journal of Biological Chemistry, 2001, vol. 276, pp. 13554-13562.
Bachner, D. et al. “Identification of melanin concentrating hormone (MCH) as the natural ligand for the orphan somatostatin-like receptor 1 (SLC-1)”, FEBS Letters, 1999, vol. 457, pp. 522-524.
Baker, B. et al. “Structure-Activity Studies With Fragments and Analogues of Salmonid Melanin-Concentrating Hormone”, Peptides, 1990, vol. 11, pp. 1103-1108.
Bednarek, M. et al. “Short Segment of Human Melanin-Concentrating Hormone That Is Sufficient for Full Activation of Human Melanin-Concentrating Hormone Receptors 1 and 2”, Biochemistry, 2001, vol. 40, pp. 9379-9386.
Breton, C. et al. “Isolation and characterization of the human melanin-concentrating hormone gene and a variant gene”, Mulecular Brain Research, 1993, vol. 18, pp. 297-310.
Chambers, J. et al. “Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1”, Nature, 1999, vol. 400, pp. 261-265.
Chimania, M. et al. “Predominant GABAB Mediated Dispersion of the Isolated Web Melanophores of the Indian Bull Frog, Rana Tigerina (Daud.)”, Indian Journal of Pharmacology, 1995, vol. 27, pp. 241-244.
Drozdz, R. et al. “(D-(p-Benzoylphenylalanine)13, Tyrosine19)-Melanin-concentrating Hormone, a Potent Analogue for MCH Receptor Crosslinking”, Journal of Peptide Science, 1999, vol. 5, pp. 234-242.
Drozdz, R. et al. “Melanin-concentrating hormone binding to mouse melanoma cells in vitro”, FEBS Letters, 1995, vol. 359, pp. 199-202.
Erickson, J. et al. “Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y”, Nature, 1996, vol. 381, pp. 415-418.
Flier, J. et al. “Obesity and the Hypothalamus: Novel Peptides for New Pathways”, Cell, 1998, vol. 92, pp. 437-440.
Hintermann, E. et al. “Synthesis and Characterization of New Radioligands for the Mammalian Melanin-Concentrating Hormone (MCH) Receptor”, Journal of Receptor & Signal Transduction Research, 1999, vol. 19, pp. 411-422.
Kawauchi, H. et al. “Characterization of melanin-concentrating hormone in chum salmon pituitaries”, Nature, 1983, vol. 305, pp. 321-323.
Knigge, K. et al. “Melanotropic Peptides in the Mammalian Brain: The Melanin-Concentrating Hormone”, Peptides, 1996, vol. 17, pp. 1063-1073.
Lebl, M. et al. “Melanin Concentrating Hormone Analogues: Contraction of the Cyclic Structure. I. Angonist Activity”, Journal of Medicinal Chemistry, 1988, vol. 31, pp. 949-954.
MacDonald, D. et al. “Molecular Characterization of the Melanin-Concentrating Hormone/Receptor Complex: Identification of Critical Residues Involved in Binding and Activation”, Molecular Pharmacology, 2000, vol. 58, pp. 217-225.
Nahon, J. “The Melanin-Concentrating Hormone: From the Peptide to the Gene”, Critical Reviews in Neurobiology, 1994, vol. 8, pp. 221-262.
Presse, F. et al. “Structure of the Human Melanin Concentrating Hormone mRNA”, Molecular Endocrinology, 1990, vol. 4, pp. 632-637.
Qu, D. et al. “A role for melanin-concentrating hormone in the central regulation of feeding behaviour”, Nature, 1996, vol. 380, pp. 243-247.
Saito, Y. et al. “Molecular characterization of the melanin-concentrating-hormone receptor”, Nature, 1999, vol. 400, pp. 265-269.
Shimada, M. et al. “Mice lacking melanin-concentrating hormone are hypophagic and lean”, Nature, 1998, vol. 396, pp. 670-674.
Shimomura, Y. et al. “Isolation and Identification of Melanin-Concentrating Hormone as the Endogenous Ligand of the SLC-1 Receptor”, Biochemical and Biophysical Research Communications, 1999, vol. 261, pp. 622-626.
Vaughan, J. et al. “Characterization of Melanin-Concentrating Hormone from Rat Hypothalamus”, Endocrinology, 1989, vol. 125, pp. 1660-1665.
Fitch Catherine D.
Gupta Anish
Heard Thomas S.
Heber Sheldon O.
Merck & Co. , Inc.
LandOfFree
Melanin-concentrating hormone analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Melanin-concentrating hormone analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Melanin-concentrating hormone analogs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3932697